Abstract
The formation of DNA adducts is considered essential for tumor initiation. Quantification of DNA adducts may be achieved by various techniques of which LC-MS/MS-based multiple reaction monitoring has become the most prominent in the past decade. Adducts of single nucleosides are analyzed following enzymatic break-down of a DNA sample following adduct enrichment usually by solid-phase extraction. LC-MS/MS quantification is carried out using stable isotope-labeled internal reference substances. An upcoming challenge is the use of DNA adducts as biomarkers either for internal exposure to electrophilic genotoxins or for the approximation of cancer risk. Here we review recent studies in which DNA adducts were quantified by LC-MS/MS in DNA samples from human matrices. We outline a possible way for future research to aim at the development of an ‘adductome’ approach for the characterization of DNA adduct spectra in human tissues. The DNA adduct spectrum reflects the inner exposure of an individual’s tissue to electrophilic metabolites and, therefore, should replace the conventional and inaccurate external exposure in epidemiological studies in the future.
This chapter is unchanged from the first edition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 2-AAF:
-
2-Acetylaminofluorene
- 4-ABP:
-
4-Aminobiphenyl
- BaP:
-
Benzo[a]pyrene
- CYP:
-
Cytochrome P450 monooxygenase
- dA:
-
2′-Deoxyadenosine
- dC:
-
2′-Deoxycytidine
- dG:
-
2′-Deoxyguanosine
- HAA:
-
Heterocyclic aromatic amine
- LC-MS/MS:
-
Liquid chromatography–tandem mass spectrometry
- MP:
-
1-Methylpyrene
- MRM:
-
Multiple reaction monitoring
- PAH:
-
Polycyclic aromatic hydrocarbon
- PhIP:
-
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
- TLC:
-
Thin-layer chromatography
References
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57–70.
International Agency for Research on Cancer. (2010). Some aromatic amines, organic dyes, and related exposures (Vol. 99). Lyon: International Agency for Research on Cancer.
International Agency for Research on Cancer. (2010). Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures (Vol. 92). Lyon: International Agency for Research on Cancer.
International Agency for Research on Cancer. (2007). Smokeless tobacco and some tobacco-specific N-nitrosamines (Vol. 89). Lyon: International Agency for Research on Cancer.
Guengerich, F. P. (2003). Activation of dihaloalkanes by thiol-dependent mechanisms. Journal of Biochemistry and Molecular Biology, 36, 20–27.
International Agency for Research on Cancer. (2008). 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide) (Vol. 97). Lyon: International Agency for Research on Cancer.
Guengerich, F. P., Johnson, W. W., Shimada, T., Ueng, Y. F., Yamazaki, H., & Langouet, S. (1998). Activation and detoxication of aflatoxin B1. Mutation Research, 402, 121–128.
Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., & Sutter, T. R. (1998). Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis, 19, 1847–1853.
Shou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., & Gelboin, H. V. (1994). The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Molecular Carcinogenesis, 10, 159–168.
Rendic, S., & Guengerich, F. P. (2012). Contributions of human enzymes in carcinogen metabolism. Chemical Research in Toxicology, 25, 1316–1383.
Otteneder, M., & Lutz, W. K. (1999). Correlation of DNA adduct levels with tumor incidence: Carcinogenic potency of DNA adducts. Mutation Research, 424, 237–247.
Poirier, M. C., & Beland, F. A. (1992). DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment. Chemical Research in Toxicology, 5, 749–755.
Randerath, K., Reddy, M. V., & Gupta, R. C. (1981). 32P-labeling test for DNA damage. Proceedings of the National Academy of Sciences of the United States of America, 78, 6126–6129.
Farmer, P. B., & Singh, R. (2008). Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: The increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens. Mutation Research, 659, 68–76.
Klaene, J. J., Sharma, V. K., Glick, J., & Vouros, P. (2012). The analysis of DNA adducts: The transition from 32P-postlabeling to mass spectrometry. Cancer Letters, 334, 10–19.
Angerer, J., Ewers, U., & Wilhelm, M. (2007). Human biomonitoring: State of the art. International Journal of Hygiene and Environmental Health, 210, 201–228.
Godschalk, R. W., Van Schooten, F. J., & Bartsch, H. (2003). A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. Journal of Biochemistry and Molecular Biology, 36, 1–11.
Phillips, D. H. (2002). Smoking-related DNA and protein adducts in human tissues. Carcinogenesis, 23, 1979–2004.
Vineis, P., & Husgafvel-Pursiainen, K. (2005). Air pollution and cancer: Biomarker studies in human populations. Carcinogenesis, 26, 1846–1855.
Poirier, M. C., Stanley, J. R., Beckwith, J. B., Weinstein, I. B., & Yuspa, S. H. (1982). Indirect immunofluorescent localization of benzo[a]pyrene adducted to nucleic acids in cultured mouse keratinocyte nuclei. Carcinogenesis, 3, 345–348.
Spodheim-Maurizot, M., Saint-Ruf, G., & Leng, M. (1980). Antibodies to N-hydroxy-2-aminofluorene modified DNA as probes in the study of DNA reacted with derivatives of 2-acetylaminofluorene. Carcinogenesis, 1, 807–812.
Baasanjav-Gerber, C., Monien, B. H., Mewis, I., Schreiner, M., Barillari, J., Iori, R., et al. (2011). Identification of glucosinolate congeners able to form DNA adducts and to induce mutations upon activation by myrosinase. Molecular Nutrition & Food Research, 55, 783–792.
Farmer, P. B., Brown, K., Tompkins, E., Emms, V. L., Jones, D. J., Singh, R., et al. (2005). DNA adducts: Mass spectrometry methods and future prospects. Toxicology and Applied Pharmacology, 207, 293–301.
Monien, B. H., Müller, C., Engst, W., Frank, H., Seidel, A., & Glatt, H. R. (2008). Time course of hepatic 1-methylpyrene DNA adducts in rats determined by isotope dilution LC-MS/MS and 32P-postlabeling. Chemical Research in Toxicology, 21, 2017–2025.
Felton, J. S., Knize, M. G., Shen, N. H., Lewis, P. R., Andresen, B. D., Happe, J., et al. (1986). The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 7, 1081–1086.
Glatt, H. R. (2006). Metabolic factors affecting the mutagenicity of heterocyclic amines. In K. Skog & J. Alexander (Eds.), Acrylamide and other health hazardous compounds in heat-treated foods (pp. 358–404). Cambridge: Woodhead Publishing.
Monien, B. H., Engst, W., Barknowitz, G., Seidel, A., & Glatt, H. R. (2012). Mutagenicity of 5-hydroxymethylfurfural in V79 cells expressing human SULT1A1: Identification and mass spectrometric quantification of DNA adducts formed. Chemical Research in Toxicology, 25, 1484–1492.
Monien, B. H., Herrmann, K., Florian, S., & Glatt, H. R. (2011). Metabolic activation of furfuryl alcohol: Formation of 2-methylfuranyl DNA adducts in Salmonella typhimurium strains expressing human sulfotransferase 1A1 and in FVB/N mice. Carcinogenesis, 32, 1533–1539.
Monien, B. H., Müller, C., Bakhiya, N., Donath, C., Frank, H., Seidel, A., et al. (2009). Probenecid, an inhibitor of transmembrane organic anion transporters, alters tissue distribution of DNA adducts in 1-hydroxymethylpyrene-treated rats. Toxicology, 262, 80–85.
Punt, A., Delatour, T., Scholz, G., Schilter, B., van Bladeren, P. J., & Rietjens, I. M. (2007). Tandem mass spectrometry analysis of N2-(trans-isoestragol-3′-yl)-2′-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1′-hydroxyestragole. Chemical Research in Toxicology, 20, 991–998.
Beland, F. A., Doerge, D. R., Churchwell, M. I., Poirier, M. C., Schoket, B., & Marques, M. M. (1999). Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chemical Research in Toxicology, 12, 68–77.
Singh, R., Gaskell, M., Le Pla, R. C., Kaur, B., Azim-Araghi, A., Roach, J., et al. (2006). Detection and quantitation of benzo[a]pyrene-derived DNA adducts in mouse liver by liquid chromatography-tandem mass spectrometry: Comparison with 32P-postlabeling. Chemical Research in Toxicology, 19, 868–878.
Goodenough, A. K., Schut, H. A., & Turesky, R. J. (2007). Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2′-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry. Chemical Research in Toxicology, 20, 263–276.
Phillips, D. H., & Castegnaro, M. (1999). Standardization and validation of DNA adduct postlabelling methods: Report of interlaboratory trials and production of recommended protocols. Mutagenesis, 14, 301–315.
Reddy, M. V. (2000). Methods for testing compounds for DNA adduct formation. Regulatory Toxicology and Pharmacology, 32, 256–263.
Paini, A., Scholz, G., Marin-Kuan, M., Schilter, B., O’Brien, J., van Bladeren, P. J., et al. (2011). Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays. Mutagenesis, 26, 605–618.
Ma, L., Kuhlow, A., & Glatt, H. R. (2002). Ethanol enhances the activation of 1-hydroxymethylpyrene to DNA adduct-forming species in the rat. Polycyclic Aromatic Compounds, 22, 933–946.
Smith, B., Cadby, P., Leblanc, J. C., & Setzer, R. W. (2010). Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic: Example: Methyleugenol, CASRN: 93-15-2. Food and Chemical Toxicology, 48(Suppl 1), S89–S97.
Ricicki, E. M., Soglia, J. R., Teitel, C., Kane, R., Kadlubar, F., & Vouros, P. (2005). Detection and quantification of N-(deoxyguano-sin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. Chemical Research in Toxicology, 18, 692–699.
Zhang, S., Balbo, S., Wang, M., & Hecht, S. S. (2010). Analysis of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chemical Research in Toxicology, 24, 119–124.
Chen, L., Wang, M., Villalta, P. W., Luo, X., Feuer, R., Jensen, J., et al. (2007). Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. Chemical Research in Toxicology, 20, 108–113.
Embrechts, J., Lemiere, F., Van Dongen, W., Esmans, E. L., Buytaert, P., Van Marck, E., et al. (2003). Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. Journal of the American Society for Mass Spectrometry, 14, 482–491.
Bessette, E. E., Spivack, S. D., Goodenough, A. K., Wang, T., Pinto, S., Kadlubar, F. F., et al. (2010). Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chemical Research in Toxicology, 23, 1234–1244.
Brown, K., Tompkins, E. M., Boocock, D. J., Martin, E. A., Farmer, P. B., Turteltaub, K. W., et al. (2007). Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose. Cancer Research, 67, 6995–7002.
Gu, D., Turesky, R. J., Tao, Y., Langouet, S. A., Nauwelaers, G. C., Yuan, J. M., et al. (2012). DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry. Carcinogenesis, 33, 124–130.
Zhu, J., Chang, P., Bondy, M. L., Sahin, A. A., Singletary, S. E., Takahashi, S., et al. (2003). Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention, 12, 830–837.
Gorlewska-Roberts, K., Green, B., Fares, M., Ambrosone, C. B., & Kadlubar, F. F. (2002). Carcinogen-DNA adducts in human breast epithelial cells. Environmental and Molecular Mutagenesis, 39, 184–192.
Perera, F., Mayer, J., Jaretzki, A., Hearne, S., Brenner, D., Young, T. L., et al. (1989). Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Research, 49, 4446–4451.
Tang, D., Phillips, D. H., Stampfer, M., Mooney, L. A., Hsu, Y., Cho, S., et al. (2001). Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Research, 61, 6708–6712.
Newcomb, P. A., Solomon, C., & White, E. (1999). Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Research and Treatment, 53, 271–277.
Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., et al. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiology, Biomarkers & Prevention, 3, 3–10.
Nair, J., Carmichael, P. L., Fernando, R. C., Phillips, D. H., Strain, A. J., & Bartsch, H. (1998). Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson’s disease and primary hemochromatosis. Cancer Epidemiology, Biomarkers & Prevention, 7, 435–440.
Bartsch, H., Arab, K., & Nair, J. (2011). Biomarkers for hazard identification in humans. Environmental Health, 10(Suppl 1), S11.
Poirier, M. C. (2004). Chemical-induced DNA damage and human cancer risk. Nature Reviews. Cancer, 4, 630–637.
Singh, R., Teichert, F., Seidel, A., Roach, J., Cordell, R., Cheng, M. K., et al. (2010). Development of a targeted adductomic method for the determination of polycyclic aromatic hydrocarbon DNA adducts using online column-switching liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 24, 2329–2340.
Chou, P. H., Kageyama, S., Matsuda, S., Kanemoto, K., Sasada, Y., Oka, M., et al. (2010). Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chemical Research in Toxicology, 23, 1442–1448.
Matsuda, T., Tao, H., Goto, M., Yamada, H., Suzuki, M., Wu, Y., et al. (2013). Lipid peroxidation-induced DNA adducts in human gastric mucosa. Carcinogenesis, 34, 121–127.
Benford, D., Bolger, P. M., Carthew, P., Coulet, M., DiNovi, M., Leblanc, J. C., et al. (2010). Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic. Food and Chemical Toxicology, (48 Suppl 1), S2–S24.
Acknowledgements
The author gratefully acknowledges financial support from the German Research Foundation (MO 2520/1-1) and the German Institute of Human Nutrition (DIfE).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Monien, B.H. (2019). Mass Spectrometric DNA Adduct Quantification by Multiple Reaction Monitoring and Its Future Use for the Molecular Epidemiology of Cancer. In: Woods, A., Darie, C. (eds) Advancements of Mass Spectrometry in Biomedical Research. Advances in Experimental Medicine and Biology, vol 1140. Springer, Cham. https://doi.org/10.1007/978-3-030-15950-4_44
Download citation
DOI: https://doi.org/10.1007/978-3-030-15950-4_44
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15949-8
Online ISBN: 978-3-030-15950-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)